A UNICEF worker checks boxes of the Moderna coronavirus vaccine after their arrival at the airport in Nairobi, Kenya, Aug. 23, 2021.
Brian Inganga / AP Photo
Moderna says its COVID booster increases protection against omicron
The company said it is continuing to work to develop an omicron-specific booster.
By Jaclyn Diaz, NPR
Brian Inganga / AP Photo
A UNICEF worker checks boxes of the Moderna coronavirus vaccine after their arrival at the airport in Nairobi, Kenya, Aug. 23, 2021.
Moderna said Monday that preliminary data showed that its COVID-19 booster shot is effective against the omicron variant of the coronavirus currently surging in the U.S. and around the world.
The pharmaceutical company said its current FDA-authorized, 50-microgram booster shot increases antibody levels against omicron 37-fold compared to pre-booster levels.
Research also showed a 100-microgram booster dose gave an even higher level of protection — an 83-fold increase in neutralizing antibody levels, Moderna said.
The news of Moderna’s findings adds more scientific backing to the idea that booster shots are an effective way to offer continued protection against the coronavirus, especially with the growing omicron variant.
“The dramatic increase in COVID-19 cases from the Omicron variant is concerning to all. However, these data showing that the currently authorized Moderna COVID-19 booster can boost neutralizing antibody levels 37-fold higher than pre-boost levels are reassuring,” said Stéphane Bancel, CEO of Moderna.
The company said it is continuing to work to develop an omicron-specific booster.
Sometimes, your mornings are just too busy to catch the news beyond a headline or two. Don’t worry. The Morning Agenda has got your back. Each weekday morning, host Tim Lambert will keep you informed, amused, enlightened and up-to-date on what’s happening in central Pennsylvania and the rest of this great commonwealth.
